CLDN18 and lung cancer: Consistent with an antitumor role of claudin-18 in lung cancer, loss of claudin-18 has been reported to activate YAP, resulting in increased abundance and proliferation of known distal lung progenitors, alveolar epithelial type II (AT2) cells, and tumorigenesis in mice (27).